Patients receiving Tiotropium + Olodaterol showed significant improvements in lung function, as measured by trough (FEV1 and FEV1 area under the curve from 0-3 hours.
SUN-101 (glycopyrrolate inhalation solution) produced statistically and clinically significant changes in forced expiratory volume in one second (trough FEV1) in bronchodilation.
The largest study to date of mortality trends in patients with acute respiratory distress syndrome (ARDS) reveals that the mortality rate has dropped considerably over a 16-year period, according to a study to be presented at CHEST 2014.
According to new research, use of electronic cigarettes (e-cigarettes) has more than tripled among students in Poland.
With the help of a $2.4 million grant from the National Institutes of Health, a Virginia Tech professor is working on a vaccine that could help smokers conquer their nicotine addiction.
A new study found that Anoro Ellipta ((umeclidinium /vilanterol) showed a statistically significant improvement in lung function compared with tiotropium for COPD patients.
A study that compared the care delivered to patients in hospital emergency departments (EDs) for acute asthma attacks with data gathered more than 15 years earlier reveals inconsistencies in how well hospitals are meeting nationally established treatment guidelines.
IntelliQuit, the world’s first personal pocket size biosensor and ecosystem that biochemically measures tobacco consumption to help smokers quit, is now available on-line via Kickstarter.
Researchers have shown for the first time how bacteria can grow directly in the lungs of cystic fibrosis patients, which has provided tremendous insights into bacteria behavior and growth in chronic infections.
Cornell researchers have demonstrated how cigarette smoke results in cell death, a contributing factor in COPD development.